ERIC DACHTLER: Open Payments
NPI 1922739218 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,453 in 114 payments from 17 companies in 2025. Trend: 2023 $2,266 · 2024 $2,036 · 2025 $2,453
Food & beverage: $2,453
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $524 |
| Vanda Pharmaceuticals Inc. | 16 | $449 |
| Alkermes, Inc. | 13 | $334 |
| ABBVIE INC. | 16 | $177 |
| E.R. Squibb & Sons, L.L.C. | 7 | $146 |
| Neurocrine BioSciences, Inc. | 7 | $140 |
| Janssen Pharmaceuticals, Inc | 5 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Lundbeck LLC | 4 | $91 |
| Corium, LLC | 3 | $79 |
Products named: FANAPT, REXULTI, ARISTADA, ABILIFY MAINTENA, VRAYLAR, COBENFY, INGREZZA, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
